Q1 2026 Gerresheimer AG Earnings Call Transcript
Key Points
- Gerresheimer AG (GRRMF) signed agreements to sell Centor and Primary Packaging Plastics for an enterprise value of approximately EUR1.5 billion, which is expected to significantly reduce debt and achieve a sustainable leverage below 3x net debt-to-EBITDA.
- The company achieved its best first-quarter free cash flow since 2019, improving by nearly EUR110 million year-over-year to minus EUR32 million, driven by disciplined working capital management and a 50% reduction in capital expenditures.
- Containment and Delivery Systems segment delivered strong organic revenue growth of 8.8%, driven by the Medical Device Systems business unit and the Peachtree ramp-up, with adjusted EBITDA increasing to EUR61 million from EUR51 million.
- Primary Injectable Solutions segment achieved 14.2% organic revenue growth, with strong performance in syringe systems more than offsetting lower revenues in Tubular Glass Europe and Asia.
- The company is executing a GTO transformation program targeting EUR50 million to EUR70 million in annualized EBITDA improvements, with full run-rate impact expected by 2028, and has initiated the closure of the Chicago Heights plant to improve Moulded Glass performance.
- Gerresheimer AG (GRRMF) maintains a solid liquidity position of EUR342 million, which is fully sufficient and compliant with covenants under its stabilization agreement, and is working on a complete refinancing supported by its banks and financial advisers.
- Adjusted EBITDA declined by EUR15 million year-over-year in Q1 2026, primarily due to lower capacity utilization and production halts in Moulded Glass, which was a conscious trade-off to strengthen cash flow.
- Moulded Glass segment revenues fell to EUR144 million from EUR160 million, with adjusted EBITDA dropping to EUR6 million from EUR32 million, impacted by furnace repairs, weak demand in cosmetics, and lower pharma container sales.
- The company faces ongoing challenges in Tubular Glass Europe, which requires a full turnaround and restructuring due to a complex footprint of smaller plants and lower profitability.
- The BaFin investigation is ongoing, and the company cannot comment on timing, adding uncertainty and potential reputational risk.
- The company's payables decreased by EUR54 million, partly due to reduced reverse factoring lines available because of its lower credit rating, which could strain supplier relationships.
- The company expects Q1 2026 to be its lowest quarter of the year, with results improving in the second half, but the full-year guidance remains unchanged, indicating limited near-term upside.
Ladies and gentlemen, welcome to the publication of preliminary Q1 2026 results of Gerresheimer (Foreign Language) Conference Call. I'm Mathilde, Chorus Call operator. (Operator Instructions) The conference is being recorded. (Operator Instructions) The conference must not be recorded for publication or broadcast.
At this time, it's my pleasure to hand over to Mr. Guido Pickert, Vice President, Corporate Investor Relations. Please go ahead.
Thank you, operator. This earnings call is based on preliminary figures for our first quarter 2026. Both Lehmann and Achim Schalk will explain the Q1 2026 performance to you and we'll give you an update on the company development. On Page 1 of the presentation, please let me remind you that the disclaimer you can find there will apply throughout this earnings call, and we assume your content to this. I will therefore not read it out loud. You can download the slide deck from our website under presentations at our Investor Relations
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
